Thoracic Surgery Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

The thoracic surgery market was valued at USD 17.94 Billion in 2025 and is expected to grow at a CAGR of 4.70%, reaching USD 28.40 Billion by 2035. Growth is supported by rising incidence of thoracic disorders and advancements in minimally invasive surgery techniques.

Thoracic Surgery Market Overview

A thoracic surgery involves any chest organ treatment or operation including the heart, lungs, oesophagus, as well as trachea. Thoracic surgery is also recognised as chest surgery. Thoracic surgery is conducted either by a minimally invasive procedure or by an open process. Thoracotomy requires a chest incision and is used to treat lung cancer.

Thoracic Surgery Market Growth Drivers

Rising Prevalence Increasing the Rates of Thoracic Surgeries

The rising prevalence of lung cancer, chronic obstructive pulmonary disease (COPD), emphysema, and heart diseases are increasing the need for thoracic surgeries. The factors contributing to the rising prevalence include higher rates of smoking, air pollution, aging populations, and lifestyle changes, all of which heighten the risk of respiratory and cardiovascular issues that require surgical intervention. For instance, as per the fact sheet released by the American Heart Association in 2024, cardiovascular disease (CVD) accounted for 931,578 deaths in the United States in 2021. Additionally, an article published by the American Cancer Society announced that around 340 deaths happen daily due to lung cancer. Also, approximately 101,300 of the 125,070 lung cancer deaths (81%) in 2024 are highly expected to be caused by cigarette smoking directly, with an additional 3500 caused by second-hand smoke.

New Fixation System Drives Thoracic Surgery Market Growth

The rising prevalence of cardiothoracic surgeries and the need for efficient post-operative recovery solutions are driving innovation in thoracic surgery devices. For instance, in August 2024, DePuy Synthes, part of Johnson & Johnson MedTech, introduced the MatrixSTERNUM™ Fixation System, a plate and screw device specifically designed for securing and stabilising the chest wall following surgeries like open-heart and thoracic procedures. This system aims to improve patient outcomes with enhanced locking strength, quicker chest fixation, and slimmer, low-profile plates that reduce discomfort and healing time. This launch is expected to significantly impact the global thoracic surgery market by setting new standards for post-operative stability and recovery. As more healthcare providers adopt advanced fixation systems, the demand for thoracic surgeries is likely to rise due to improved patient outcomes and faster recovery. Additionally, DePuy Synthes’ focus on patient-specific solutions may encourage other companies to innovate, driving market growth through enhanced product development in the forecast period.

Thoracic Surgery Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Technological Advancements Drives Market Growth

The thoracic surgery market is experiencing significant growth, driven by advances in minimally invasive and robotic-assisted surgical technologies. These innovations offer less invasive approaches to traditional thoracic procedures, leading to faster recovery times, fewer complications, and enhanced precision. As a result, healthcare providers and patients alike are increasingly opting for these modern solutions, boosting market demand. In September 2023, Medtronic plc launched its Penditure™ Left Atrial Appendage (LAA) Exclusion System in the United States. The Penditure LAA Exclusion System is an innovative, implantable clip designed to aid in LAA management during cardiac surgeries. This single-use delivery system allows the clip to be repositioned, recaptured, and redeployed, offering unmatched precision. With its curved design for optimal anatomical fit and fabric-free closure to minimise inflammation, the Penditure™ clip provides atraumatic, controlled LAA closure. With rising cases of lung cancer, emphysema, and other thoracic diseases globally, the need for efficient, high-quality surgical options continues to expand. This growth trend highlights the potential for technological improvements to transform thoracic surgery into a safer and more effective field.

Growing Prevalence of Diseases to Drives Thoracic Surgery Market Demand

The prevalence of respiratory and thoracic conditions like lung cancer and chronic obstructive pulmonary disease (COPD) is fueling growth in the thoracic surgery market. According to the World Health Organization, COPD is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. The major contributing factors to this condition are tobacco consumption and smoking accounting for around 70% of COPD cases in high-income countries. As global rates of smoking, air pollution, and aging populations contribute to a rise in thoracic disease, the demand for thoracic surgery is accelerating. This increased prevalence has spurred healthcare systems to enhance resources for thoracic surgeries and diagnostics, further boosting the market. Expansion of healthcare facilities specializing in thoracic conditions and growing investment in thoracic surgical services reflect the market's steady development in response to heightened medical needs.

Specialisation in Services to Increase Thoracic Surgery Market Value

The increasing focus on specialized thoracic surgery services is elevating the market's overall value. Hospitals and medical centers are investing in skilled thoracic surgeons and state-of-the-art equipment to meet the growing demand for precise and specialized procedures. Additionally, insurance companies are beginning to recognize the value of thoracic surgery, improving reimbursement policies and making these procedures more accessible to patients. With the rise in specialization, the market value is expected to grow as healthcare providers leverage cutting-edge surgical techniques and expertise to improve patient outcomes, making thoracic surgery more integral to modern healthcare.

Growing Awareness and Accessibility Enhance Thoracic Surgery Market Reach

Greater awareness of thoracic conditions and improved accessibility to surgical options are expanding the market reach for thoracic surgery. Public health campaigns and medical education initiatives are informing patients about early detection and treatment options for thoracic diseases, which increases surgical referrals and demand. Additionally, the rise of healthcare facilities in developing regions is helping patients access thoracic surgery options. With better awareness and easier access to specialised care, the market is set to reach more diverse patient populations, strengthening its overall growth trajectory.

Thoracic Surgery Market Segmentation

Market Breakup by Product

• Surgical Sutures and Staples
• Electrosurgical Devices
• Handheld Surgical Equipment

Market Breakup by Application

• Lobectomy
• Wedge Resection
• Pneumonectomy
• Others

Market Breakup by End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Thoracic Surgery Market Share

Handheld Surgical Equipment Leads Thoracic Surgery Market Segment by Product

Handheld surgical equipment is likely to hold the largest market share within the thoracic surgery market’s product segment due to its versatility and essential role across various surgical procedures. These tools, including forceps, retractors, and scalpels, offer precision, ease of use, and are crucial in both open and minimally invasive surgeries, driving their high demand. The increasing adoption of minimally invasive techniques and advancements in equipment design have enhanced their effectiveness, further expanding the market. As healthcare providers seek high-quality tools that improve surgical outcomes, the segment is poised for strong growth, supporting the broader thoracic surgery market in the forecast period.

Lobectomy Segment to Lead the Thoracic Surgery Market Segmentation by Application

Lobectomy procedures are expected to hold the largest share within the application segment, driven by the high incidence of lung cancer and other respiratory conditions requiring lung tissue removal. As lobectomy is a common treatment for early-stage lung cancer, demand has surged with rising cases globally. The effectiveness of lobectomy in extending survival rates among patients further bolsters its popularity and market dominance. With continued advancements in surgical techniques, particularly minimally invasive lobectomy, the segment is poised to grow significantly, reinforcing its role in driving thoracic surgery market expansion over the coming years.

Hospitals and Clinics Segment Holds Largest Thoracic Surgery Market Share in End User Segment

Hospitals and clinics are poised to dominate the end user segment due to their capacity to perform complex surgical procedures and house specialised surgical teams. The availability of advanced technologies and a higher volume of surgeries performed at these facilities further boost the segment market share. As patient demand for quality healthcare services rises, hospitals and clinics continue to invest in cutting-edge thoracic surgery equipment and skilled professionals. This trend is expected to drive further growth, with hospitals and clinics strengthening their role as primary end users in the thoracic surgery market during the forecast period.

Thoracic Surgery Market Analysis by Region

North America is projected to lead the market due to its advanced healthcare infrastructure, strong presence of specialised surgical centres, and high adoption of cutting-edge surgical technologies. The region has a significant number of thoracic surgeons and specialised care facilities, enabling complex procedures with greater frequency and precision. Additionally, the rising prevalence of lung cancer and other thoracic diseases, combined with proactive screening initiatives, drives substantial demand for thoracic surgeries. North America’s commitment to research and innovation also fuels continuous advancements in surgical techniques, ensuring the region’s strong market position and growth potential in the thoracic surgery sector.

Leading Players in the Thoracic Surgery Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Boston Scientific Corporation

Headquartered in Marlborough, Massachusetts, Boston Scientific Corporation was established in 1979 and is a global leader in medical devices, particularly for cardiovascular, endoscopy, and urology. The company’s portfolio includes innovative thoracic and minimally invasive surgical devices. Recently, it has focused on expanding its portfolio with new products and acquisitions to strengthen its market presence.

Medtronic plc

Founded in 1949, Medtronic plc is headquartered in Dublin, Ireland, and is one of the largest medical device companies globally. Its portfolio spans cardiovascular, surgical, and neurological devices, with a strong presence in thoracic surgery solutions. Medtronic recently announced advancements in minimally invasive technologies, reinforcing its commitment to improving patient outcomes in thoracic care.

AtriCure, Inc.

AtriCure, Inc., based in Mason, Ohio, was founded in 2000 and specialises in treatments for atrial fibrillation and thoracic surgery. Its product range includes ablation devices and advanced surgical solutions for treating thoracic conditions. The company has been expanding its clinical trial initiatives, supporting innovative solutions and boosting its market footprint in thoracic and cardiac care.

Abbott Laboratories

Abbott Laboratories, headquartered in Abbott Park, Illinois, was established in 1888. It provides a wide range of healthcare products, including thoracic and cardiovascular devices, diagnostics, and nutritional products. Abbott has recently focused on enhancing its diagnostic and surgical devices portfolio, particularly for minimally invasive procedures, to meet growing healthcare demands. In January 2023, Abbott received approval from the U.S. Food and Drug Administration (FDA) for its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor™, for patients with severe aortic stenosis, allowing for valve replacement without open-heart surgery. It is the latest addition to the company's comprehensive transcatheter structural heart portfolio that offers less invasive treatment options to physicians and patients for some of the most common and serious heart diseases.

BioVentrix, Inc.

BioVentrix, Inc., headquartered in San Ramon, California, was founded in 2003 and focuses on advanced heart failure and thoracic solutions. Its portfolio includes minimally invasive therapies for ventricular reduction, enhancing outcomes for thoracic surgery patients. The company recently gained significant attention for its novel Revivent TC System, which addresses heart failure with a less invasive approach.

Other key players in the market include Becton, Dickinson and Company, Teleflex Incorporated, Terumo Corporation, Zimmer Biomet Holdings, Inc., and Edwards Lifesciences Corporation.

Key Questions Answered in the Thoracic Surgery Market

• What was the global thoracic surgery market value in 2025?
• What is the thoracic surgery market forecast outlook for 2026-2035?
• What is market segmentation based on product?
• What is market segmentation based on application?
• How is the market segmented based on end users?
• What are the major factors aiding the thoracic surgery market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• Which country is expected to experience expedited growth during the forecast period?
• What are the major global thoracic surgery market trends?
• Which product will lead the market segment?
• Which application will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the global thoracic surgery market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?